Prognostic impact of tumour volume and lymph node involvement in intermediate stage T1b1 to T2b cancer of the uterine cervix;Impact pronostique du volume tumoral et du statut ganglionnaire dans les cancers du col de l'utérus de stades intermédiaires T1b1 à T2b

Bulletin du Cancer

Volumn 96, Issue 6, 2009, Pages 685-694

  Goudy, G ^a   Stoeckle, E ^a   Thomas, L ^a   Kind, M ^a   Guyon, F ^a   Brouste, V ^a   Floquet, A ^a  

^a INSTITUT BERGONIÉ   (France)

Author keywords

Cancer of the uterine cervix; Laparoscopic pelvic lymphadenectomy; Lymph node involvement; Magnetic resonance imaging; Prognostic factors; Tumour volume

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; PROGNOSIS; RADIOLOGY; RISK ASSESSMENT; SCORING SYSTEM; SURVIVAL RATE; TUMOR VOLUME; UNIVARIATE ANALYSIS; UTERINE CERVIX CANCER; UTERUS; ANALYSIS OF VARIANCE; LYMPHADENECTOMY; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PELVIS; RETROSPECTIVE STUDY; SURVIVAL; UTERINE CERVIX TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; PELVIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 67651046990     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2009.0873     Document Type: Article

References (32)

1. Standards, options et recommandations (SOR). In : FNCLCC, SFOG, eds. Cancers invasifs du col utérin. Stades non métastatiques. Paris : John Libbey Eurotext, 1999.
2. Querleu D, Leblanc E, Castelain B. Laparoscopic pelvic lymphadenectomy in the staging of early carcinoma of the cervix. Am J Obstet Gynecol 1991 ; 164 : 579-581
3. Pairoux R, Stoeckle E, Tribondeau P, Tunon de Lara C, Monnin D, Thomas L. Lymphadénectomie pelvienne par coelioscopie dans le cancer du col utérin. À propos de 35 cas. J Coeliochir 1996 ; 18 : 15-22.
4. Dekindt C, Stoeckle E, Thomas L, Floquet A, Kind M, Brouste V, et al. Lymphadénectomie interiliaque percoelioscopique dans le cancer du col de l'utérus : toujours le gold standard? À propos des rechutes ganglionnaires après lymphadénectomie chez 190 patientes traitées. J Gynecol Obstet Biol Reprod (Paris) 2005 ; 34 : 473-480 (Pubitemid 41243098)
5. Perez CA, Grigsby PW, Nene SM, Camel HM, Galakatos A, Kao MS, et al. Effect of tumour size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 1992 ; 69 : 2796-2806
6. Fyles AW, Pintilie M, Kirkbride P, Levin W, Manchul LA, Rawlings GA. Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis. Radiother Oncol 1995 ; 35 : 107-117
7. Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, et al. Carcinoma of the cervix uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006 ; 95 (Suppl 1) : S43-103.
8. Yeh SA, Wan Leung S, Wang CJ, Chen HC. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors. Gynecol Oncol 1999 ; 72 : 10-15 (Pubitemid 29045440)
9. Trattner M, Graf AH, Lax S, Forstner R, Dandachi N, Haas J, et al. Prognostic factors in surgically treated stage Ib-IIb cervical carcinomas with special emphasis on the importance of tumour volume. Gynecol Oncol 2001 ; 82 : 11-16 (Pubitemid 32634947)
10. Atlan D, Touboul E, Deniaud-Alexandre E, Lefranc JP, Ganansia V, Bernard A, et al. Cancer du col utérin stades IB et II opérables : comparaison rétrospective entre curiethérapie utérovaginale préopératoire et chirurgie première, suivies d'une radiothérapie. Cancer Radiother 2002 ; 6 : 217-237 (Pubitemid 34886272)
11. Barillot I, Horiot JC, Pigneux J, Schraub S, Pourquier H, Daly N, et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostics factors. Int J Radiat Oncol Biol Phys 1997 ; 38 : 969-978 (Pubitemid 27353675)
12. Grigsby PW, Perez CA, Chao KS, Elbendary A, Herzog TJ, Rader JS, et al. Lack of effect of tumour size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery. Int J Radiat Oncol Biol Phys 1999 ; 45 : 645-651 (Pubitemid 29462645)
13. Lai CH, Hong JH, Hsueh S, Kwan Ng K, Chang TC, Tseng CJ, et al. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases. Cancer 1999 ; 85 : 1537-1546 (Pubitemid 29152826)
14. Kodama J, Seki N, Nakamura K, Hongo A, Hiramatsu Y. Prognostic factors in pathologic parametrium-positive patients with stage IB-IIB cervical cancer treated by radical surgery and adjuvant therapy. Gynecol Oncol 2007 ; 105 : 757-761 (Pubitemid 46734207)
15. Morice P, Castaigne D, Pautier P, Rey A, Haie-Meder C, Leblanc M, et al. Interest of pelvic and para-aortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol 1999 ; 73 : 106-110 (Pubitemid 29177608)
16. Creasman WT, Kohler MF. Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? Gynecol Oncol 2004 ; 92 : 525-529
17. Morrow CP. Is pelvic radiation beneficial in the postoperative management of stage IB squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? Gynecol Oncol 1980 ; 10 : 105-110
18. Inoue T, Morita K. The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA and IIB. Cancer 1990 ; 65 : 1923-1927 (Pubitemid 20147629)
19. Tsai CS, Lai CH, Wang CC, Chang JT, Chang TC, Tseng CJ, et al. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Gynecol Oncol 1999 ; 75 : 328-333
20. Takeda N, Sakuragi N, Takeda M, Okamoto K, Kuwabara M, Negishi H, et al. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand 2002 ; 81 : 1144-1151 (Pubitemid 35454363)
21. Horn LC, Hentschel B, Galle D, Bilek K. Extracapsular extension of pelvic lymph node metastases is of prognostic value in carcinoma of the cervix uteri. Gynecol Oncol 2008 ; 108 : 63-67 (Pubitemid 350299422)
22. Kamura T, Tsukamoto N, Tsuruchi N, Saito T, Matsuyama T, Akazawa K, et al. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer 1992 ; 69 : 181-186
23. Ho CM, Chien TY, Huang SH, Wu CJ, Shih BY, Chang SC. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy. Gynecol Oncol 2004 ; 93 : 458-464 (Pubitemid 38507618)
24. Tanaka Y, Sawada S, Murata T. Relationship between lymph node metastases and prognosis in patients irradiated postoperatively for carcinoma of the uterine cervix. Acta Radiol Oncol 1984 ; 23 : 455-459 (Pubitemid 15073560)
25. Burghardt E, Baltzer J, Tulusan AH, Haas J. Results of surgical treatment of 1,028 cervical cancers studied with volumetry. Cancer 1992 ; 70 : 648-655
26. Burghardt E, Hofmann HM, Ebner F, Haas J, Tamussino K, Justich E. Magnetic resonance imaging in cervical cancer: a basis for objective classification. Gynecol Oncol 1989 ; 33 : 61-67 (Pubitemid 19106625)
27. Hricak H, Quivey JM, Campos Z, Gildengorin V, Hindmarsh T, Bis KG, et al. Carcinoma of the cervix: predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factors. Int J Radiat Oncol Biol Phys 1993 ; 27 : 791-801. (Pubitemid 23340288)
28. Mayr NA, Yuh WT, Zheng J, Ehrhardt JC, Sorosky JI, Magnotta VA, et al. Tumour size evaluated by pelvic examination compared with 3-D quantitative analysis in the prediction of outcome for cervical cancer. Int J Radiat Oncol Biol Phys 1997 ; 39 : 395-404. (Pubitemid 27392506)
29. Eifel PJ, Morris M, Wharton JT, Oswald MJ. The influence of tumour size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994 ; 29 : 9-16. (Pubitemid 24138859)
30. Soutter WP, Hanoch J, D'Arcy T, Dina R, McIndoe GA, DeSouza NM. Pre-treatment tumour volume measurement on high-resolution magnetic resonance imaging as a predictor of survival in cervical cancer. BJOG 2004 ; 111 : 741-747 (Pubitemid 38869764)
31. Toita T, Kakinohana Y, Shinzato S, Ogawa K, Yoshinaga M, Iraha S, et al. Tumour diameter/volume and pelvic node status assessed by magnetic resonance imaging (MRI) for uterine cervical cancer treated with irradiation. Int J Radiat Oncol Biol Phys 1999 ; 43 : 777-782 (Pubitemid 29152649)
32. Finan MA, DeCesare S, Fiorica JV, Chambers R, Hoffman MS, Kline RC, et al. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival? Gynecol Oncol 1996 ; 62 : 139-147